Screener
Anika Therapeutics ANIK Business Segments — Selling General And Administrative Expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Anika Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001171843-26-005012
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 21,244 | 14,363 | 40,241 | 29,044 |
| Operating expenses: | ||||
| Research & development | 7,341 | 6,313 | 14,054 | 12,372 |
| Selling, general & administrative | 10,949 | 12,230 | 28,721 | 25,136 |
| Total operating expenses | 18,290 | 18,543 | 42,775 | 37,508 |
| Income (loss) from operations | 2,954 | (4,180) | (2,534) | (8,464) |
| Interest and other income, net | 426 | 214 | 1,093 | 629 |
| Income (loss) before income taxes | 3,380 | (3,966) | (1,441) | (7,835) |
ITEM 1. FINANCIAL STATEMENTS[ Item 1. Condensed Consolidated Financial Statements (unaudited): ](#)
FAQ
- What is Anika Therapeutics's business segments — selling general and administrative expense?
- Anika Therapeutics (ANIK) reported business segments — selling general and administrative expense of $10.95M in Q2 2026.
- What does business segments — selling general and administrative expense mean?
- This includes all overhead costs related to sales, marketing, and general corporate administration required to support the orthopedic business. It provides insight into the company's operational efficiency and the cost structure required to maintain market presence.
Ask your AI about Anika Therapeutics's business segments — selling general and administrative expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude